Aclarion (NasdaqCM:ACON) Conference October 20, 2025 03:00 PM ET Company ParticipantsBrent Ness - CEOConference Call ParticipantsNone - AnalystBrent NessZero debt, no preferred shares outstanding, no near-term warrant overhang. We are fully NASDAQ compliant, meeting both bid price and shareholder equity requirements. We have private payer approvals in London, and we'll talk later about why that's so important to the future growth trajectory of the business. We have scan volume growth. Again, the second prob ...